Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7716
+0.0136 (1.79%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Operating Income Operating Income Growth | -50.25 | -50.63 | -60.77 | -61.35 | -63.52 | -65.11 | -29.61 | -25.52 | -18.47 | -16.28 | -13.69 | -18.19 | -24.24 | -27.65 | -29.76 | -30.07 | -28.04 | -26.61 | -23.98 | -22.22 |
Net Income Net Income Growth | -50.21 | -49.87 | -58.89 | -59.15 | -61.27 | -62.88 | -29.24 | -25.22 | -18.07 | -15.73 | -12.94 | -17.48 | -23.69 | -27.33 | -29.58 | -29.92 | -27.61 | -26.16 | -24.36 | -22.68 |
Earnings Per Share EPS Growth | -1.90 | -1.96 | -2.94 | -3.00 | -3.17 | -3.51 | -3.15 | -3.28 | -3.22 | -3.42 | -2.84 | -3.84 | -5.21 | -6.02 | -6.51 | -6.51 | -5.95 | -5.89 | -6.60 | -7.80 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 4.45 | 3.22 | 4.05 | 5.72 | 7.43 | 12.87 | 17.68 | 21.94 | 12.07 | 17.34 | 12.09 | 13.69 | 16.75 | 21.27 | 25.5 | 32.41 | 38.1 | 45.96 | 52.26 | 59.5 |
Total Debt Total Debt Growth | 4.92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0 | 0 | 0 | 0.03 | 0.07 | 0.1 | 0.13 | 0.16 | 0.19 | 0.22 |
Net Cash (Debt) Net Cash Growth | -0.48 | 3.22 | 4.05 | 5.72 | 7.43 | 12.87 | 17.68 | 21.94 | 12.07 | 17.29 | 12.09 | 13.69 | 16.75 | 21.23 | 25.44 | 32.31 | 37.97 | 45.8 | 52.07 | 59.28 |
Net Cash Growth | - | -75.01% | -77.10% | -73.92% | -38.44% | -25.59% | 46.16% | 60.27% | -27.94% | -18.57% | -52.45% | -57.62% | -55.90% | -53.63% | -51.15% | -45.50% | -39.52% | 226.86% | 475.05% | 332.75% |
Net Cash Per Share Net Cash Per Share Growth | -0.02 | 0.13 | 0.17 | 0.26 | 0.35 | 0.72 | 1.29 | 2.34 | 2.18 | 3.76 | 2.66 | 3.01 | 3.69 | 4.68 | 5.61 | 7.13 | 8.38 | 10.31 | 13.64 | 18.66 |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27 | -25.08 | -23.75 | -22.19 | -19.97 |
Capital Expenditures CapEx Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | -0.01 | -0.07 | -0.16 | -0.16 | -0.15 |
Free Cash Flow Free Cash Flow Growth | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27.01 | -25.15 | -23.91 | -22.35 | -20.12 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |